AETERNUM HEALTH, INC. (AETN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60K 120K 180K Q4 '19: 0 Q2 '22: 3K Q3 '22: 6.5K Q4 '22: 10.1K Q1 '23: 2.6K Q2 '23: 11.8K Q3 '23: 2.5K Q3 '23: 3.7K Q4 '23: 2.8K Q4 '23: 259 Q1 '24: 1.2K Q1 '24: 3.8K Q2 '24: 33.4K Q3 '24: 15.4K Q4 '24: 12.3K Q1 '25: 164.7K Q2 '25: 7.1K Q3 '25: 8.3K Q4 '25: 23.5K Q1 '26: 2.3K Q2 '22 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26

Gross Profit Quarterly

-50K 0 50K 100K 150K Q2 '22: -7.7K Q3 '22: -3.3K Q4 '22: -3.4K Q1 '23: -8.9K Q2 '23: -587 Q3 '23: -6.1K Q3 '23: -15.9K Q4 '23: -8.4K Q1 '24: -20.6K Q1 '24: -8.8K Q2 '24: 32.5K Q3 '24: -14.9K Q4 '24: -21.5K Q1 '25: 125.4K Q2 '25: -5.6K Q3 '25: -8.6K Q4 '25: 9K Q1 '26: -12K Q4 '22 Q3 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26

Operating Income Quarterly

-300K -200K -100K 0 100K 200K 300K Q2 '22: -55.5K Q3 '22: -52.7K Q4 '22: -60.6K Q1 '23: -89.8K Q2 '23: -99K Q3 '23: -281.9K Q3 '23: -110.6K Q4 '23: -99.6K Q4 '23: -69.3K Q1 '24: -103.7K Q1 '24: -105.4K Q2 '24: -92.6K Q3 '24: -110.1K Q4 '24: -122.4K Q1 '25: 22.7K Q2 '25: -88.7K Q3 '25: -120.9K Q4 '25: -82.4K Q1 '26: -119.5K Q2 '26: -270.9K Q3 '22 Q2 '23 Q4 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-600K 0 600K 1.2M 1.8M Q4 '22: -59.5K Q1 '23: -101.7K Q1 '23: -101.7K Q2 '23: -115.1K Q2 '23: -301.9K Q3 '23: -312.4K Q3 '23: -141K Q4 '23: -103.5K Q4 '23: -88.4K Q1 '24: -131K Q1 '24: -117.5K Q2 '24: -116.3K Q3 '24: -77.2K Q4 '24: -139.3K Q1 '25: 5.9K Q2 '25: -105.9K Q3 '25: -137.9K Q4 '25: -99.3K Q1 '26: -139.7K Q2 '26: 1.7M Q1 '23 Q2 '23 Q4 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 10K 20K 30K Q2 '22: 10.7K Q3 '22: 9.8K Q4 '22: 11.8K Q1 '23: 11.3K Q2 '23: 10.9K Q3 '23: 7.5K Q3 '23: 17.4K Q4 '23: 9.5K Q1 '24: 21.5K Q3 '24: 28.9K Q3 '22 Q1 '23 Q3 '23 Q4 '23 Q3 '24

Operating Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q1 '22: -12.3K Q2 '22: -97.4K Q3 '22: -26.3K Q4 '22: -30.6K Q1 '23: -149.1K Q2 '23: -122K Q3 '23: 85.5K Q4 '23: -86K Q4 '23: -144.5K Q1 '24: -63.2K Q1 '24: -100.4K Q2 '24: -44.6K Q3 '24: -8K Q4 '24: -1K Q1 '25: -18.3K Q2 '25: 18.3K Q3 '25: 35.6K Q4 '25: -38.5K Q1 '26: -56.2K Q2 '26: -1.5M Q2 '22 Q1 '23 Q4 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '20: 3.6M Q4 '20: 3.6M Q2 '21: 6.6M Q3 '21: 5.2M Q4 '21: 7.1M Q2 '22: 8.8M Q3 '22: 8.8M Q4 '22: 9.4M Q2 '23: 47.4M Q3 '23: 48.2M Q3 '23: 47.8M Q4 '23: 48.5M Q1 '24: 42.5M Q2 '24: 48.5M Q3 '24: 48.5M Q1 '25: 48.6M Q2 '25: 49.2M Q3 '25: 49.2M Q1 '26: 50.3M Q2 '26: 54.7M Q4 '20 Q4 '21 Q4 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.01 Q2 '18: -0.01 Q3 '18: -0.02 Q4 '18: -0.02 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: -0.04 Q4 '21: -0.05 Q1 '22: -0.35 Q2 '22: -0.35 Q3 '22: -0.30 Q4 '22: -0.30 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '26: -0.01 Q2 '26: 0.02 Q3 '17 Q2 '18 Q4 '20 Q3 '21 Q2 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.